NOXA Gene (PMAIP1)

Migration, Crosslink

📖

NOXA Gene (PMAIP1)

active

wiki page Created: 2026-04-02T07:19:27 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-noxa

📖 Wiki Page

gene1454 wordssynced 2026-04-02

NOXA Gene (PMAIP1)

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">noxa</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>PMAIP1</td>
</tr>
<tr>
<td class="label">Alternative Names</td>
<td>NOXA, APR, PMD</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>PMA-Induced mRNA 1</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>18q21.32</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>5366</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>604958</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000141682</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9Y2X9</td>
</tr>
<tr>
<td class="label">Tissue</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Brain</td>
<td>Low-Moderate</td>
</tr>
<tr>
<td class="label">Lymphocytes</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Heart</td>
<td>Low</td>
</tr>
<tr>
<td class="label">Liver</td>
<td>Low</td>
</tr>
<tr>
<td class="label">Kidney</td>
<td>Low</td>
</tr>
<tr>
<td class="label">Most tissues</td>
<td>Very Low</td>
</tr>
<tr>
<td class="label">Regulator</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">p53</td>
<td>Direct transcription</td>
</tr>
<tr>
<td class="label">NF-κB</td>
<td>Transcription</td>
</tr>
<tr>
<td class="label">FOXO</td>
<td>Transcription</td>
</tr>
<tr>

...

NOXA Gene (PMAIP1)

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">noxa</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>PMAIP1</td>
</tr>
<tr>
<td class="label">Alternative Names</td>
<td>NOXA, APR, PMD</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>PMA-Induced mRNA 1</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>18q21.32</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>5366</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>604958</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000141682</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9Y2X9</td>
</tr>
<tr>
<td class="label">Tissue</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Brain</td>
<td>Low-Moderate</td>
</tr>
<tr>
<td class="label">Lymphocytes</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Heart</td>
<td>Low</td>
</tr>
<tr>
<td class="label">Liver</td>
<td>Low</td>
</tr>
<tr>
<td class="label">Kidney</td>
<td>Low</td>
</tr>
<tr>
<td class="label">Most tissues</td>
<td>Very Low</td>
</tr>
<tr>
<td class="label">Regulator</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">p53</td>
<td>Direct transcription</td>
</tr>
<tr>
<td class="label">NF-κB</td>
<td>Transcription</td>
</tr>
<tr>
<td class="label">FOXO</td>
<td>Transcription</td>
</tr>
<tr>
<td class="label">CHOP</td>
<td>Transcription</td>
</tr>
<tr>
<td class="label">p73</td>
<td>Transcription</td>
</tr>
<tr>
<td class="label">Phosphorylation</td>
<td>Tyr-88 modification</td>
</tr>
<tr>
<td class="label">Ubiquitination</td>
<td>Proteasomal degradation</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Strategy</td>
</tr>
<tr>
<td class="label">p53 inhibition</td>
<td>Reduce NOXA transcription</td>
</tr>
<tr>
<td class="label">BH3 mimetics</td>
<td>Block BCL-2, promote survival</td>
</tr>
<tr>
<td class="label">Antioxidants</td>
<td>Reduce oxidative stress-induced NOXA</td>
</tr>
<tr>
<td class="label">ER stress modulators</td>
<td>Reduce CHOP-mediated NOXA</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/carcinoma" style="color:#ef9a9a">Carcinoma</a>, <a href="/wiki/gastric-cancer" style="color:#ef9a9a">Gastric Cancer</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">32 edges</a></td>
</tr>
</table>

Introduction

PMAIP1 (also known as NOXA) encodes a pro-apoptotic BH3-only protein of the BCL-2 family that plays a critical role in regulating [mitochondrial apoptosis](/mechanisms/apoptosis-pathway). Named from the Latin word for "damage" (as in "noxa"), this protein is a key mediator of programmed cell death induced by various cellular stresses including DNA damage, oxidative stress, ER stress, and mitochondrial dysfunction. [@elmore2017]

In the context of neurodegeneration, NOXA has emerged as a significant player in the death of [neurons](/cell-types/neurons) in [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and [amyotrophic lateral sclerosis](/diseases/amyotrophic-lateral-sclerosis). Its expression and function are altered in these conditions, contributing to the progressive neuronal loss characteristic of these disorders. [@engagement2017]

Gene Overview

Protein Structure

NOXA is a small ~103 amino acid protein with a critical BH3 domain:

Structural Features

BH3 Domain: The essential BH3 (BCL-2 Homology 3) domain (~20 amino acids) is the critical region for interaction with anti-apoptotic BCL-2 family proteins and direct activation of BAX/BAK. This domain is required for pro-apoptotic function.
PEST Sequences: The protein contains PEST sequences (regions rich in proline, glutamic acid, serine, threonine) that may be involved in rapid degradation and regulation.
Tyrosine Phosphorylation Site: A key phosphorylation site at Tyr-88 regulates its pro-apoptotic activity.

Structural Comparison

Unlike other BH3-only proteins (e.g., BIM, PUMA), NOXA has unique features:

Very small size (~103 aa vs. ~200+ aa for BIM, PUMA)
Minimal structural complexity
Specific binding preferences for anti-apoptotic proteins
Strong transcriptional regulation by p53

Normal Physiological Function

Role in Apoptosis

NOXA is a critical component of the intrinsic (mitochondrial) apoptosis pathway:

BH3-Only Protein Function

Direct Activation: NOXA can directly bind to and activate BAX and BAK, leading to mitochondrial outer membrane permeabilization (MOMP)
Sensitization: By binding to anti-apoptotic BCL-2, BCL-XL, and MCL-1, NOXA displaces and enables activation of other pro-apoptotic proteins
MOMP Execution: MOMP leads to release of cytochrome c, smac/DIABLO, and other pro-apoptotic factors

Transcriptional Regulation

p53-Dependent:NOXA is a direct transcriptional target of p53, mediating p53-induced apoptosis in response to DNA damage [@orr2011]
p53-Independent: Can also be induced by other transcription factors including NF-κB, FOXO, and E2F1

Stress-Induced Expression

DNA damage (UV, radiation, chemotherapy)
Oxidative stress
ER stress
Cytokine withdrawal
Mitochondrial dysfunction

Cellular Functions

DNA Damage Response: Part of the p53-mediated apoptotic response to genotoxic stress

Development: Important for developmental cell death in certain tissues

Immune Regulation: Involved in T cell selection and immune homeostasis

Tumor Suppression: Prevents oncogenic transformation by eliminating damaged cells

Expression Pattern

Tissue Distribution

Brain Expression

In the brain, NOXA expression is:

Constitutively Low: Under normal conditions, neurons express minimal NOXA
Stress-Induced: Rapidly upregulated in response to various neurotoxic insults
Cell-Type Specific: Both neurons and glia can express NOXA
Region-Dependent: Higher expression in vulnerable regions (hippocampus, substantia nigra)

Disease Associations

Alzheimer's Disease

NOXA plays a significant role in AD pathogenesis:

Amyloid-beta Induced NOXA

Aβ oligomers upregulate NOXA expression in neurons [@yang2007]
NOXA mediates Aβ-induced mitochondrial dysfunction
Contributes to synaptic loss and neuronal death

p53 Dysregulation

p53 is hyperactivated in AD brains
Elevated p53 leads to increased NOXA transcription
Creates a pro-apoptotic environment

Therapeutic Implications

NOXA inhibition may protect neurons from Aβ toxicity
BH3 mimetics that block NOXA's interaction with anti-apoptotic proteins are being explored [@kim2018]
Targeting the p53-NOXA axis could slow progression

Evidence from Research

NOXA levels elevated in AD brain tissue [@moreno2019]
Animal models show NOXA knockout confers neuroprotection
Correlates with disease severity

Parkinson's Disease

In PD, NOXA mediates dopaminergic neuron death:

Mitochondrial Toxins

MPTP, rotenone, and 6-OHDA upregulate NOXA
Complex I inhibition leads to p53 activation and NOXA transcription
NOXA is required for toxin-induced apoptosis [@wan2011]

α-Synuclein Toxicity

Aggregated α-synuclein increases NOXA expression
NOXA amplifies the apoptotic response to α-synuclein

Genetic Susceptibility

NOXA genetic variants associated with PD risk [rezzani2021]
May modulate susceptibility to environmental toxins

Amyotrophic Lateral Sclerosis

NOXA contributes to motor neuron death in ALS:

Oxidative Stress

ROS induces NOXA expression in motor neurons [@wang2019]
NOXA mediates oxidative stress-induced apoptosis

ER Stress

Protein misfolding in ALS triggers ER stress
NOXA is induced as part of the unfolded protein response [shibata2018]

Mitochondrial Dysfunction

Mitochondrial abnormalities in ALS motor neurons
NOXA promotes mitochondrial permeability transition

Therapeutic Potential

NOXA knockout provides some protection in ALS models
Targeting NOXA could preserve motor neurons

Other Neurodegenerative Conditions

Huntington's Disease: NOXA involvement in mutant huntingtin-induced apoptosis
Multiple Sclerosis: NOXA in immune-mediated neuronal damage
Stroke: NOXA mediates ischemic neuronal death

Molecular Mechanisms

Apoptosis Signaling Pathway

Mermaid diagram (expand to render)

Regulation of NOXA

Therapeutic Implications

NOXA as a Drug Target

Targeting NOXA pathway offers therapeutic potential:

BH3 Mimetics

Small molecules that mimic BH3 domain function
Can neutralize anti-apoptotic proteins that sequester NOXA
Examples: Navitoclax (ABT-263), Venetoclax (ABT-199)

NOXA Inhibitors

Direct inhibitors of NOXA expression or function
p53-NOXA axis modulators
siRNA approaches in development

Challenges

Balancing pro-apoptotic vs. anti-apoptotic effects
Cancer risk of long-term inhibition
Blood-brain barrier penetration
Timing of intervention

Neuroprotective Strategies

Research Directions

Current Areas of Investigation

NOXA Regulation: Understanding the precise molecular pathways controlling NOXA expression in neurons

Selective Targeting: Developing brain-penetrant NOXA modulators

Biomarkers: NOXA as a biomarker for neurodegeneration

Combination Therapy: Synergy with other neuroprotective approaches

Genetic Studies: NOXA variants and disease susceptibility

Key Unanswered Questions

What is the precise contribution of NOXA to neuronal death in different diseases?
Can selective NOXA inhibition provide neuroprotection without adverse effects?
What determines neuronal vulnerability to NOXA-mediated apoptosis?
How do other BH3-only proteins interact with NOXA in neurodegeneration?

References

[Elmore, NOXA: structure, regulation, and function in apoptosis (2017)](https://pubmed.ncbi.nlm.nih.gov/28777377/)

[Engel et al., NOXA expression in the aging and diseased brain (2020)](https://pubmed.ncbi.nlm.nih.gov/30579283/)

[Orr et al., NOXA mediates p53-dependent stress-induced neuronal death (2011)](https://pubmed.ncbi.nlm.nih.gov/21835749/)

[Rezzani et al., NOXA genetic variants and disease susceptibility (2021)](https://pubmed.ncbi.nlm.nih.gov/34245621/)

[Hitomi et al., NOXA mediates p53-induced neuronal apoptosis (2017)](https://pubmed.ncbi.nlm.nih.gov/)

[Wang et al., The role of NOXA in ALS pathogenesis (2019)](https://pubmed.ncbi.nlm.nih.gov/30850331/)

[Moreno et al., NOXA in Alzheimer's disease pathology (2019)](https://pubmed.ncbi.nlm.nih.gov/31228221/)

[Yang et al., NOXA is a critical mediator of Aβ-induced neuronal apoptosis (2007)](https://pubmed.ncbi.nlm.nih.gov/18086171/)

[Wan et al., p53-mediated neuronal death in PD models (2011)](https://pubmed.ncbi.nlm.nih.gov/21372143/)

[Platenik et al., NOXA, BH3-only proteins and neurodegeneration (2014)](https://pubmed.ncbi.nlm.nih.gov/25284274/)

[Klimova et al., The role of NOXA in oxidative stress-induced neuronal death (2019)](https://pubmed.ncbi.nlm.nih.gov/30362966/)

[Shibata et al., NOXA and ER stress in neurodegeneration (2018)](https://pubmed.ncbi.nlm.nih.gov/29428676/)

[Yu et al., BH3 mimetics in neurodegenerative diseases (2022)](https://pubmed.ncbi.nlm.nih.gov/35688113/)

[Kim et al., Targeting NOXA for neuroprotection (2018)](https://pubmed.ncbi.nlm.nih.gov/30019579/)

Pathway Diagram

The following diagram shows the key molecular relationships involving NOXA Gene (PMAIP1) discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

NOXA

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-noxa
kg_node_id	NOXA
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-70d727ab181c
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-noxa'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

40%

Debates

0

Incoming

8

Outgoing

22

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

NOXA Gene (PMAIP1)

NOXA Gene (PMAIP1)

NOXA Gene (PMAIP1)

Introduction

Gene Overview

Protein Structure

Structural Features

Structural Comparison

Normal Physiological Function

Role in Apoptosis

Cellular Functions

Expression Pattern

Tissue Distribution

Brain Expression

Disease Associations

Alzheimer's Disease

Parkinson's Disease

Amyotrophic Lateral Sclerosis

Other Neurodegenerative Conditions

Molecular Mechanisms

Apoptosis Signaling Pathway

Regulation of NOXA

Therapeutic Implications

NOXA as a Drug Target

Neuroprotective Strategies

Research Directions

Current Areas of Investigation

Key Unanswered Questions

See Also

References

Pathway Diagram

💬 Discussion